Influence of the Toll-Like Receptor 9 1635A/G Polymorphism on the CD4 Count, HIV Viral Load, and Clinical Progression

Journal of Acquired Immune Deficiency Syndromes

Volumn 49, Issue 2, 2008, Pages 128-135

  Soriano Sarabia, Natalia ^a   Vallejo, Alejandro ^a   Ramirez Lorca, Reposo ^b   Rodriguez, Maria Del Mar ^a   Salinas, Ana ^b   Pulido, Ildefonso ^a   Sáez, Maria E ^b   Leal, Manuel ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b Neocodex SL ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TLR2 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; REAL TIME POLYMERASE CHAIN REACTION; SEROPREVALENCE; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS LOAD; DNA SEQUENCE; GENETICS; HOMOZYGOTE; IMMUNOLOGY; MOLECULAR GENETICS; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; REGRESSION ANALYSIS; TRANSITION TEMPERATURE; VIROLOGY;

ADULT; CD4 LYMPHOCYTE COUNT; FEMALE; GENOTYPE; HIV INFECTIONS; HOMOZYGOTE; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; REGRESSION ANALYSIS; SEQUENCE ANALYSIS, DNA; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9; TRANSITION TEMPERATURE; VIRAL LOAD;

EID: 55249122420     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318184fb41     Document Type: Article

References (34)

1. Gordon S. Pattern recognition receptors: doubling up for the innate immune response. Cell. 2002;111:927-930.
2. Akira S, Takeda K, Kaisho T Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol. 2001;2:675-680.
3. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol. 2003;21:335-376.
4. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124:783-801.
5. Hajjar AM, O'Mahony DS, Ozinsky A, et al. Cutting edge: functional interactions between toll-like receptor (TLR)2 and TLR1 or TLR6 in response to phenol soluble modulin. J Immunol. 2001;166:15-19.
6. Takeuchi O, Hoshino K, Hawai T, et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity. 1999;11:443-451.
7. Tal G, Mandelberg A, Dalal I, et al. Association between common toll-like receptor 4 mutations and severe respiratory syncytial virus disease. J Infect Dis. 2004;189:2057-2063.
8. Lorenz E, Mira JP, Cornish KL, et al. A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun. 2000;68:6398-6401.
9. Texereau J, Chiche JD, Taylor W, et al. The importance of toll-like receptor 2 polymorphisms in severe infections. Clin Infect Dis. 2005;41:S408S415.
10. Agnese DM, Calvano JE, Hahm SJ, et al. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J Infect Dis. 2002; 186: 1522-1525.
11. Lorenz E, Mira JP, Frees KL, et al. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med. 2002;162:1028-1032.
12. Smirnova I, Mann N, Dois A, et al. Assay of locus-specific genetic load implicates rare toll-like receptor 4 mutations in meningococcal susceptibility. Proc Natl Acad Sci USA. 2003;100:6075-6080.
13. Equils O, Faure E, Thomas L, et al. Bacterial lipopolysaccharide activates HIV long terminal repeat through toll-like receptor 4. J Immunol. 2001; 166:2342-2347.
14. Equils O, Schito ML, Karahashi H, et al. Toll-like receptor 2 (TLR2) and TLR9 signalling results in HIV-long terminal repeat trans-activation and HIV replication in HIV-1 transgenic mouse spleen cells: implications of simultaneous activation of TLRs on HIV replication. J Immunol. 2003; 170:5159-5164.
15. Tachado SD, Zhang J, Zhu J, et al. HIV impairs TNF-α release in response to toll-like receptor 4 stimulation in human macrophages in vitro. Am J Respir Cell Mol Biol. 2005;33:610-621.
16. Equils O, Salehi KK, Cornataeanu R, et al. Repeated lipopolysaccharide (LPS) exposure inhibits HIV replication in primary human macrophages. Microbes Infect. 2006;8:2469-2476.
17. Ferweda B, Kibiki GS, Netea MG, et al. The toll-like receptor 4 Asp299Gly variant and tuberculosis susceptibility in HIV-infected patients in Tanzania. AIDS. 2007;21:1375-1377.
18. Bochud PY, Hersberger M, Taffe P, el al, and the Swiss HIV cohort Study. Polymorphisms in toll-like receptor 9 influence the clinical course of HIV1 infection. AIDS. 2007;21:441-446.
19. Sutherland AM, Walley KR, Russell JA. Polymorphisms in CD 14, mannose-binding lectin, and toll-like receptor-2 are associated with increased prevalence of infection in critically ill adults. Crit Care Med. 2005;33:638-644.
20. Bochud PY, Magaret AS, Koelle DM, et al. Polymorphisms in TLR2 are associated with increased viral shedding and lesional rate in patients with genital herpes simplex virus type 2 infection. J Infect Dis. 2007;196: 497-498.
21. Montes AH, Asensi V, Alvarez V, et al. The toll-like receptor 4 (Asp299Gly) polymorphism is a risk factor for gram-negative and haematogenous osteomielitis. Clin Exp Immunol. 2006;143:404-413.
22. Sánchez E, Orozco G, Lopez-Nevot MA, et al. Polymorphisms of toll-like receptor 2 and 4 genes in rheumatoid arthritis and systemic lupus erythematosus. Tissue Antigens. 2004;63:54-57.
23. Sasieni PD. From genotypes to genes: doubling the sample size. Biometrics. 1997;53:1253-1261.
24. Institute of Human Genetics. Available at: http://ihg.gsf.de.
25. Del Corno M, Gauzzi MC, Penna G, et al. Human immunodeficiency virus type 1 gp120 and other activation stimuli are highly effective in triggering alpha interferon and CC chemokine production in circulating plasmacytoid but not myeloid dendritic cells. J Virol. 2005;79:12597-12601.
26. Martinelli E, Cicala C, Van Ryk D, et al. HIV-1 gp120 inhibits TLR9mediated activation and IFN-α secretion in plasmacytoid dendritic cells. Proc Natl Acad Sci USA. 2007;104:3396-3401.
27. Lund J, Sato A, Akira S, et al. Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med. 2003; 108:513-520.
28. Lund JM, Alexopoulo L, Sato A, et al. Recognition of single-stranded RNA viruses by toll-like receptor 7. Proc Natl Acad Sci USA. 2004;101: 5598-5603.
29. Hornung V, Rothenfusser S, Britsch S, et al. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral mononuclear cells and sensitivity to CpG olygodeoxynucleolides. J Immunol. 2002;168:4531-4537.
30. Siegal FP, Kadowaki N, Shodell M, et al. The nature of the principal type 1 interferon-producing cells in human blood. Science. 1999;284:18351837.
31. Ishii KJ, Coban C, Akira S. Manifold mechanisms of TLR-ligand recognition. J Clin Immunol. 2005;25:511-521.
32. Berghöfer B, Haley G, Frommer T, et al. Natural and synthetic TLR7 ligands inhibit CpG-A- and CpG-C- oligodeoxynucleotide-induced IFNproduction. J Immunol. 2007; 178:4072-4079.
33. Egger M, May M, Chêne G, et al, and the ART Cohort Collaboration. Prognosis of HIV-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet. 2002;360: 119-129.
34. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12:1365-1671.